Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/156778Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Marcovitch, Harvey | - |
| dc.contributor.author | Barbour, Virginia | - |
| dc.contributor.author | Borrell i Thió, Carme | - |
| dc.contributor.author | Bosch, Fèlix | - |
| dc.contributor.author | Fernández Muñoz, Esteve | - |
| dc.contributor.author | Macdonald, Helen | - |
| dc.contributor.author | Marusic, Ana | - |
| dc.contributor.author | Nylenna, Magne | - |
| dc.date.accessioned | 2020-04-22T10:06:21Z | - |
| dc.date.available | 2020-04-22T10:06:21Z | - |
| dc.date.issued | 2010-02-01 | - |
| dc.identifier.issn | 0353-9504 | - |
| dc.identifier.uri | https://hdl.handle.net/2445/156778 | - |
| dc.description.abstract | A systematic review and meta-analysis suggests that around 2% of scientists admit to have falsified research at least once. Up to 33% admit other questionable practices such as plagiarism, duplicate publication, undisclosed changes in pre-research protocols or dubious ethical behavior. There can be no doubt that discovered cases of research and publication misconduct represent a tip of an iceberg and many cases go unreported. | - |
| dc.format.extent | 9 p. | - |
| dc.format.mimetype | application/pdf | - |
| dc.language.iso | eng | - |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3325/cmj.2010.51.7 | - |
| dc.relation.ispartof | Croatian Medical Journal, 2010, vol. 51, num. 1, p. 7-15 | - |
| dc.relation.uri | https://doi.org/10.3325/cmj.2010.51.7 | - |
| dc.rights | cc-by-nd (c) Marcovitch, Harvey et al., 2010 | - |
| dc.rights.uri | http://creativecommons.org/licenses/by-nd/3.0/es | - |
| dc.source | Articles publicats en revistes (Ciències Clíniques) | - |
| dc.subject.classification | Recerca | - |
| dc.subject.classification | Indústria farmacèutica | - |
| dc.subject.classification | Discussió | - |
| dc.subject.other | Research | - |
| dc.subject.other | Pharmaceutical industry | - |
| dc.subject.other | Discussion | - |
| dc.title | Conflict of interest in science communication: more than a financial issue. Report from Esteve Foundation discussion group, April 2009 | - |
| dc.type | info:eu-repo/semantics/article | - |
| dc.type | info:eu-repo/semantics/publishedVersion | - |
| dc.identifier.idgrec | 607119 | - |
| dc.date.updated | 2020-04-22T10:06:21Z | - |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
| dc.identifier.pmid | 20162740 | - |
| Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 607119.pdf | 265.63 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
